One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Paper mill-backed writers: Here, there and everywhere?Â
John A McGrath, Shehnaz AhmedÂ
doi : 10.1093/bjd/ljae227
Volume 191, Issue 2, August 2024
How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab
doi : 10.1093/bjd/ljae165
New prospective cohort study and Mendelian randomization analysis reveal a link between psoriasis and cardiovascular risk via elevated plasma triglycerides
doi : 10.1093/bjd/ljae129
Use of a large patient database to analyse disease burden and treatment patterns among patients with vitiligo
doi : 10.1093/bjd/ljae166
Shedding light on the smoke: unravelling the impact of smoking cessation on psoriasis development
doi : 10.1093/bjd/ljae163
Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy
doi : 10.1093/bjd/ljae211
Dystrophic epidermolysis bullosa: from disease biology to biologic therapy
doi : 10.1093/bjd/ljae182
Bursting the bubble on diagnostics: artificial intelligence in autoimmune bullous disease
doi : 10.1093/bjd/ljae197
Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate
doi : 10.1093/bjd/ljae114
Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial
doi : 10.1093/bjd/ljae111
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trialÂ
doi : 10.1093/bjd/ljae067
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 yearsÂ
doi : 10.1093/bjd/ljae131
Elevated plasma triglycerides increase the risk of psoriasis: a cohort and Mendelian randomization study
doi : 10.1093/bjd/ljae089
Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UKÂ
doi : 10.1093/bjd/ljae133
Effect of smoking cessation on psoriasis vulgaris, palmoplantar pustulosis and generalized pustular psoriasis
doi : 10.1093/bjd/ljae130
Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)Â
doi : 10.1093/bjd/ljae150
Acceptability of ‘as needed’ biologic therapy in psoriasis: insights from a multistakeholder mixed-methods studyÂ
doi : 10.1093/bjd/ljae068
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin
doi : 10.1093/bjd/ljae110
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseasesÂ
doi : 10.1093/bjd/ljae142
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial
doi : 10.1093/bjd/ljae063
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis
doi : 10.1093/bjd/ljae069
Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programme
doi : 10.1093/bjd/ljae145
Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1
doi : 10.1093/bjd/ljae170
Expanding global health dermatology leadership: launching the GLODERM international mentorship programmeÂ
doi : 10.1093/bjd/ljae164
Causal effect of elevated body mass index on hidradenitis suppurativa: a two-sample Mendelian randomization study
doi : 10.1093/bjd/ljad380
A qualitative study of psychological morbidity in paediatric survivors of Stevens–Johnson syndrome/toxic epidermal necrolysis
doi : 10.1093/bjd/ljae154
High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma
doi : 10.1093/bjd/ljae171
Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study
doi : 10.1093/bjd/ljae172
A cross-sectional study of erythromelalgia in patients with pachyonychia congenita
doi : 10.1093/bjd/ljae143
‘Substantial clinical benefit’ and ‘substantial clinical worsening’ cutoff of Vitiligo Impact Scale (VIS)-22 change scores
doi : 10.1093/bjd/ljae178
New British Skin Foundation/Skin Health Alliance Psychodermatology Research Award now availableÂ
doi : 10.1093/bjd/ljae261
Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
doi : 10.1093/bjd/ljad520
